Healius Limited
ASX: HLS.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Paul D. Anderson
- Employees
- 4,329
- Headquarters
- Sydney, Australia
- IPO year
- 1998
- Market cap
- A$359.4M
- Website
- https://www.healius.com.au
Loading HLS…
Loading profile data…Frequently asked questions about HLS
What does Healius Limited (HLS.AX) do?
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plast...
Where does HLS.AX trade?
Healius Limited (HLS.AX) trades on the Australian Securities Exchange.
What sector is HLS.AX in?
Healius Limited (HLS.AX) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Healius Limited?
Paul D. Anderson is the chief executive officer of Healius Limited (HLS.AX).
Where is Healius Limited headquartered?
Healius Limited is headquartered in Australia.
Does HLS.AX pay a dividend?
Yes — Healius Limited (HLS.AX) paid a trailing twelve-month dividend of AUD 0.41 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HLS.AX go public?
Healius Limited (HLS.AX) completed its initial public offering in 1998.